![David Goldstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Goldstein
Technik-/Wissenschafts-/F&E-Leiter bei
ALUMIS INC.
Vermögen: 6 Mio $ am 30.06.2026
Profil
David M.
Goldstein is Director at Frontier Medicines Corp.
since 2021.
Dr. Goldstein is Chief Scientific Officer at Alumis, Inc. since 2021.
Dr. Goldstein is Meetings Manager at International Society for Pharmacoeconomics & Outcomes Research since 2012.
Formerly, Dr. Goldstein was Senior Director-Medicinal Chemistry at Roche Holding AG from 1994 to 2011.
Dr. Goldstein was Chief Scientific Officer at Principia Biopharma, Inc. from 2016 to 2020.
Dr. Goldstein was Assistant Professor at Stanford University.
Dr. Goldstein earned a doctorate from the University of Virginia and completed undergraduate studies at Franklin & Marshall College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALUMIS INC. 0.18% | 05.05.2026 | 221’620 ( 0.18% ) | 6 Mio $ | 30.06.2026 |
Aktive Positionen von David Goldstein
| Unternehmen | Position | Beginn |
|---|---|---|
| ALUMIS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2021 |
Frontier Medicines Corp.
 Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Develops medicines that redefine the course of debilitating diseases | Direktor/Vorstandsmitglied | 30.03.2021 |
International Society for Pharmacoeconomics & Outcomes Rsch
 International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services Provides health care researches | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von David Goldstein
| Unternehmen | Position | Ende |
|---|---|---|
| PRINCIPIA BIOPHARMA INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2020 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01.01.2011 |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von David Goldstein
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
68
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Franklin & Marshall College
 Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Society for Pharmacoeconomics & Outcomes Rsch
International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services Provides health care researches | Commercial Services |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Develops medicines that redefine the course of debilitating diseases | Health Technology |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
Wählen Sie MarketScreener 
